Hope Rugo: Importance of monitoring and active management by the MDT
Hope Rugo, Professor of medicine at the University of California San Francisco, shared a post on X:
“SABCS24 PRO B weekly surveys triggering clinic alerts and patient contact compared to no alert with every 3 mo surveys improved fatigue and possibly OS.
Importance of monitoring and active management by the MDT!!
Need data on interventions and treatment.”
Dr. Hope Rugo, is a professor of medicine at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. With experience in hematology and oncology, she specializes in breast cancer treatment and clinical trials.
Dr. Rugo’s research focuses on innovative therapies and combination treatments to improve outcomes for breast cancer patients, including immunotherapy and targeted agents. She is known for her contributions to reducing treatment toxicity educating through initiatives like the Breast Forum.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023